(Q44071252)

29 November 2017

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate (English)

1 reference

hypereosinophilic syndrome

29 November 2017

1 reference

idiopathic hypereosinophilic syndrome

inferred from title

1 reference

1 reference

5

Hagop Kantarjian

1 reference

29 November 2017

2

Jorge Cortes

1 reference

29 November 2017

1

Patricia Ault

1 reference

29 November 2017

Charles Koller

3

1 reference

PubMed ID

12127565

29 November 2017

Elizabeth S Kaled

series ordinal

4

1 reference

29 November 2017

1 September 2002

1 reference

29 November 2017

1 reference

29 November 2017

26

1 reference

29 November 2017

881-884

1 reference

29 November 2017

9

1 reference

The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Therapy of the hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Cyclosporin for hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

STI571: a magic bullet?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Mitral valve replacement in idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Allogeneic bone marrow transplantation in a patient with hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Possible participation of a JAK2 signaling pathway in recombinant rat interleukin-5-induced prolongation of rat eosinophil survival

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

The mechanism of IL-5 signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Human peripheral blood eosinophils express stem cell factor

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Activation of Human Eosinophils by Platelet-Derived Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900046-2

7 January 2021

10.1016/S0145-2126(02)00046-2

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12127565